New Botox for Foreheads
Reported March 17, 2009
(Ivanhoe Newswire) A new kind of Botox could be the answer for forehead wrinkles.
Used abroad for more than 15 years to treat neurological disorders and wrinkles, Reloxin a new Clostridium botulinum toxin type A has been shown to be well tolerated and improve the appearance of severe forehead lines in recent America studies.
Small doses of Reloxin were injected into 1,200 patients at five injection sites in the forehead. Up to five consecutive treatments were administered over the next 13-months, with a minimum of 85 days between injections.
Most patients (93 to 95 percent) reported a response to treatment within one week of treatment and maintained the clinical effect over the duration of the study with multiple treatments. Adverse effects were experienced by 808 patients, including injection site reactions and nervous system disorders, like headache and eye drooping.
Notably, Medicis Pharmaceutical Corporation, who manufacturers Reloxin, provided funding for this study, and the co-author of the study owns stock in and consults for Medicis.
SOURCE: Archives of Facial Plastic Surgery, 2009;11:77-83
